5,251
Views
86
CrossRef citations to date
0
Altmetric
Research Article

Nano-gold displayed anti-inflammatory property via NF-kB pathways by suppressing COX-2 activity

& ORCID Icon
Pages 1149-1158 | Received 11 Dec 2017, Accepted 25 Feb 2018, Published online: 19 Mar 2018

References

  • Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001;344:907–916.
  • Iwamoto T, Okamoto H, Toyama Y, et al. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J. 2008;275:4448–4455.
  • Jones BA, Riegsecker S, Rahman A, et al. Role of ADAM-17, p38 MAPK, cathepsins, and the proteasome pathway in the synthesis and shedding of fractalkine/CX(3) CL1 in rheumatoid arthritis. Arthritis Rheum. 2013;65:2814–2825.
  • Lark MW, Bayne EK, Flanagan J, et al. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Investig. 1997;100:93–106.
  • Lawrence T. The nuclear factor NF-kappaB pathway in inflammation . Cold Spring Harb Perspect Biol. 2009;1:a001651
  • Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation. Sig Transduct Target Ther. 2017;2:17023.
  • Dejardin E. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem Pharmacol. 2006;72:1161–1179.
  • Seeger DR, Cosalich DDB, Smith JM, et al. Analogs of pteroylglutamic acid. II. 4-aminoderivatives. J Am Chem Soc. 1949;71:1297–1301.
  • Gubner R, August S, Ginsberg V. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci. 1951;221:1762–1782.
  • Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov. 2003;2:473–488.
  • Scott DL, Kingsley GH. Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med. 2006;355:704–712.
  • Khan MJ, Husain Q. Influence of pH and temperature on the activity of SnO2-bound α-amylase: a genotoxicity assessment of SnO2 nanoparticles. Prep Biochem Biotechnol. 2014;44:558–571.
  • Khan MJ, Qayyum S, Alam F, et al. Effect of tin oxide nanoparticle binding on the structure and activity of α-amylase from Bacillus amyloliquefaciens. Nanotechnology. 2011a;22:455708.
  • Rao K, Aziz S, Roome T, et al. Gum acacia stabilized silver nanoparticles based nano-cargo for enhanced anti-arthritic potentials of hesperidin in adjuvant induced arthritic rats. Artif Cells Nanomed Biotechnol. 2018 [Jan 30]; [11 p.]. DOI:https://doi.org/10.1080/21691401.2018.1431653
  • Warnasooriya N, Joud F, Bun P, et al. Imaging gold nanoparticles in living cell environments using heterodyne digital holographic microscopy. Opt Express. 2010;18:3264–3273.
  • Sokolov K, Follen M, Aaron J, et al. Real-time vital optical imaging of precancer using antiepidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res. 2003;63:1999–2004.
  • Tsai CY, Shiau AL, Cheng PC, et al. A biological strategy for fabrication of Au/EGFP nanoparticle conjugates retaining bioactivity. Nano Lett. 2004;4:1209–1212.
  • Levy R, Thanh NT, Doty RC, et al. Rational and combinatorial design of peptide capping ligands for gold nanoparticles. J Am Chem Soc. 2004;126:10076–10084.
  • Liu X, Dai Q, Austin L, et al. A one-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J Am Chem Soc. 2008;130:2780–2782.
  • Tang D, Yuan R, Chai Y. Biochemical and immunochemical characterization of the antigen-antibody reaction on a non-toxic biomimetic interface immobilized red blood cells of crucian carp and gold nanoparticles. Biosens Bioelectron. 2007;22:1116–1120.
  • Bagheri S, Yasemi M, Safaie-Qamsari E, et al. Using gold nanoparticles in diagnosis and treatment of melanoma cancer. Artif Cells Nanomed Biotechnol. 2018 [Jan 26]; [10 p.]. DOI:https://doi.org/10.1080/21691401.2018.1430585
  • El-Sayed IH, Huang X, El-Sayed MA. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 2005;5:829–834.
  • Medley CD, Smith JE, Tang Z, et al. Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Anal Chem. 2008;80:1067–1072.
  • Golchin K, Golchin J, Ghaderi S, et al. Gold nanoparticles applications: from artificial enzyme till drug delivery. Artif Cells Nanomed Biotechnol. 2018;46:250–254.
  • Malik T, Chauhan G, Rath G, et al. Efaverinz and nano-gold-loaded mannosylated niosomes: a host cell-targeted topical HIV-1 prophylaxis via thermogel system. Artif Cells Nanomed Biotechnol. 2017 [Dec 12]; [12 p.]. DOI:https://doi.org/10.1080/21691401.2017.1414054
  • Daraee H, Eatemadi A, Abbasi E, et al. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 2016;44:410–422.
  • Gottlieb NL, Smith PM, Smith EM. Gold excretion correlated with clinical course during chrysotherapy in rheumatoid arthritis. Arthritis Rheum. 1972;15:582–592.
  • Thakor AS, Jokerst J, Zavaleta C, et al. Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett. 2011;11:4029–4036.
  • McFarland AD, Haynes CL, Mirkin CA, et al. Color my nanoworld. J Chem Educ. 2004;81:544A.
  • Campo GM, Avenoso A, Campo S, et al. Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res Ther. 2003;5:R122–R131.
  • Holmdahl R, Carlsen S, Mikulowska A, et al. Genetic analysis of murine models for rheumatoid arthritis. In: Adolpho KW, editor. Human genome methods. New York: CRC Press; 1998. p. 215–238.
  • Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90:37–43.
  • Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;27:502–522.
  • Hyc A, Osiecka-Iwan A, Dziunycz P, et al. Preparation of rat synovial membrane for studies of cytokine secretion. Folia Histochem Cytobiol. 2007;45:57–60.
  • Khan MS, Halagowder D, Devaraj SN. Methylated chrysin induces coordinated attenuation of the canonical Wnt and NF-kB signaling pathway and up-regulates apoptotic gene expression in the early hepatocarcinogenesis rat model. Chem Biol Interact. 2011b;193:12–21.
  • Adán N, Guzmán-Morales J, Ledesma-Colunga MG, et al. Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. J Clin Investig. 2013;123:3902–3913.
  • Zhang L, Sun T, Yu E, et al. TNF-α expression, not iNOS expression, is correlated with NF-κB activation in the spinal cord of rats following peripheral nerve injury. Afr J Biotechnol. 2011;10:6372–6380.
  • Hu PJ, Yu J, Zeng ZR, et al. Chemoprevention of gastric cancer by celecoxib in rats. Gut. 2004;53:195–200.
  • Azizian M, Bathaie SZ, Ashrafi M, et al. Investigation of p53 and p27 expressions in the N-nitroso-N-methylureainduced breast cancer in female Wistar Albino rats. Physiol Pharmacol. 2014;18:337–346.
  • Schmittgen TD, Zakrajsek BA, Mills AG, et al. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem. 2000;285:194–204.
  • Sun X, Jiang X, Dong S, et al. One-step synthesis and size control of dendrimer-protected gold nanoparticles: a heat-treatment-based strategy. Macromol Rapid Commun. 2003;24:1024–1028.
  • Hu J, Wang Z, Li J. Gold nanoparticles with special shapes: controlled synthesis, surface-enhanced Raman scattering, and the application in biodetection. Sensors. 2007;7:3299–3311.
  • Tsai CY, Shiau AL, Chen SY, et al. Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis Rheum. 2007;56:544–554.
  • Brown CL, Bushell G, Whitehouse MW, et al. Nanogold-pharmaceutics. Gold Bull. 2007;40:245–250.
  • Pandey S. Various techniques for the evaluation of anti arthritic activity in animal models. J Adv Pharm Technol Res. 2010;1:164–171.
  • Bendele A. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact. 2001;1:377–385.
  • El-Ansary MR, Eldin TAS, Ali OMS, et al. Functionalized gold nanoparticles for inhibition of vascular endothelial growth factor in arthritic patients. J Nanomed Res. 2015;2:00036.
  • Dinarello C. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest. 1997;112:321S–329S.
  • Palladino M, Bahjat F, Theodorakis E, et al. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov. 2003;2:736–746.
  • Isomaki P, Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med. 1997;29:499–507.
  • Szekanecz Z, Halloran MM, Volin MV, et al. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum. 2000;43:1266–1277.
  • Rengel Y, Ospelt C, Gay S. Proteinases in the joint: clinical. Relevance of proteinases in joint destruction. Arthritis Res Ther. 2007;9:221.
  • Umar S, Umar K, Sarwar AH, et al. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine. 2014;21:847–856.
  • Sun Y, Zhao DL, Liu ZX, et al. Beneficial effect of 20-hydroxyecdysone exerted by modulating antioxidants and inflammatory cytokine levels in collagen-induced arthritis: a model for rheumatoid arthritis. Mol Med Rep. 2017;16:6162–6169.
  • Taysi S, Polat F, Gul M, et al. Lipid peroxidation, some extracellular anti-oxidants, and anti-oxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int. 2002;21:200–204.
  • Sul OJ, Kim JC, Kyung TW, et al. Gold nanoparticles inhibited the receptor activator of nuclear factor-κb ligand (RANKL)-induced osteoclast formation by acting as an antioxidant. Biosci Biotechnol Biochem. 2010;74:2209–2213.
  • Connor EE, Mwamuka J, Gole A, et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1:325–327.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.